A Urine Test That Could Change the Course of Bladder Cancer Care - Stanford Medicine
A Urine Test That Could Change the Course of Bladder Cancer Care Stanford Medicine
Bladder Cancer News
Meri-Margaret Deoudes on patient engagement in bladder cancer care - Urology Times
Meri-Margaret Deoudes on patient engagement in bladder cancer care Urology Times
Indi-Blade Study Tests Ipilimumab-Nivolumab Followed by Chemoradiotherapy in Advanced Bladder Cancer - Michiel Van Der Heijden & Jan-Jaap Mellema - UroToday
Indi-Blade Study Tests Ipilimumab-Nivolumab Followed by Chemoradiotherapy in Advanced Bladder Cancer - Michiel Van Der Heijden & Jan-Jaap Mellema UroToday
Doctors Say This Is the Number-1 Sign of Bladder Cancer - Prevention
Doctors Say This Is the Number-1 Sign of Bladder Cancer Prevention
Bladder Cancer: Urine Test Improves Relapse Predictions - Inside Precision Medicine
Bladder Cancer: Urine Test Improves Relapse Predictions Inside Precision Medicine
Outlining Emergent Bladder Cancer Insights at Columbia University - CancerNetwork
Outlining Emergent Bladder Cancer Insights at Columbia University CancerNetwork
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study - TMX Newsfile
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study TMX Newsfile
All treated animals stayed cancer-free in Theralase bladder study - Stock Titan
All treated animals stayed cancer-free in Theralase bladder study Stock Titan
ctDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer - OncLive
ctDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer OncLive
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - Yahoo Finance
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check Yahoo Finance
Nuclear hexokinase 2 couples hyperglycemia to MYC-driven glycolytic and stemness programs in bladder cancer - Nature
Nuclear hexokinase 2 couples hyperglycemia to MYC-driven glycolytic and stemness programs in bladder cancer Nature
FDA Plans Reclassification Move for Diagnostic Light Systems Used in Bladder Cancer Care - TipRanks
FDA Plans Reclassification Move for Diagnostic Light Systems Used in Bladder Cancer Care TipRanks
IU researchers play role in development of new bladder cancer treatment - Indianapolis Business Journal
IU researchers play role in development of new bladder cancer treatment Indianapolis Business Journal
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery - Fox Chase Cancer Center
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery Fox Chase Cancer Center
ACRIN 8192 Evaluates Preoperative Gemcitabine Plus Durvalumab in Cisplatin-Ineligible UTUC - Jeannie Hoffman-Censits - UroToday
ACRIN 8192 Evaluates Preoperative Gemcitabine Plus Durvalumab in Cisplatin-Ineligible UTUC - Jeannie Hoffman-Censits UroToday
Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer - Yale School of Medicine
Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer Yale School of Medicine
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms - ASCO Publications
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms ASCO Publications
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - NEJM
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer NEJM
Study finds link between colorblindness and death from bladder cancer - Stanford Medicine
Study finds link between colorblindness and death from bladder cancer Stanford Medicine
New drug developed at UC Davis offers hope to bladder cancer patients - University of California - Davis Health
New drug developed at UC Davis offers hope to bladder cancer patients University of California - Davis Health
Urine DNA test predicts bladder cancer recurrence and guides BCG therapy - Labmate Online
Urine DNA test predicts bladder cancer recurrence and guides BCG therapy Labmate Online
Colour blindness as a risk factor for bladder cancer - Nature
Colour blindness as a risk factor for bladder cancer Nature
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients - Memorial Sloan Kettering Cancer Center
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients Memorial Sloan Kettering Cancer Center
Perioperative outcomes following open radical cystectomy in the setting of locally advanced bladder cancer - springermedicine.com
Perioperative outcomes following open radical cystectomy in the setting of locally advanced bladder cancer springermedicine.com
Can ctDNA Predict Metastatic Risk in Bladder Cancer? - Oncology News Central
Can ctDNA Predict Metastatic Risk in Bladder Cancer? Oncology News Central
Hypoxia-inducible factor 1α exerts dual roles in bladder cancer progression through TIMP3-mediated regulation of angiogenesis and invasion | Scientific Reports - Nature
Hypoxia-inducible factor 1α exerts dual roles in bladder cancer progression through TIMP3-mediated regulation of angiogenesis and invasion | Scientific Reports Nature
Advances in the management of localized bladder cancers - Nature
Advances in the management of localized bladder cancers Nature
New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations - ImmunityBio
New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations ImmunityBio
USC study suggests type 1 diabetes may significantly raise bladder cancer risk - Keck School of Medicine of USC
USC study suggests type 1 diabetes may significantly raise bladder cancer risk Keck School of Medicine of USC
Mayo Clinic expert highlights improved survival in muscle-invasive bladder cancer and kidney cancer - Mayo Clinic News Network
Mayo Clinic expert highlights improved survival in muscle-invasive bladder cancer and kidney cancer Mayo Clinic News Network
Bladder Cancer Remission Rate: What Patients Need to Know in 2025 - Oncodaily
Bladder Cancer Remission Rate: What Patients Need to Know in 2025 Oncodaily
A multi-modal approach for decision making in bladder cancer - Nature
A multi-modal approach for decision making in bladder cancer Nature
Non-Invasive Urine Test Improves Prediction of Bladder Cancer Treatment Outcomes: Study - Medical Dialogues
Non-Invasive Urine Test Improves Prediction of Bladder Cancer Treatment Outcomes: Study Medical Dialogues
Top 10 Urology Times bladder cancer articles of 2025 - Urology Times
Top 10 Urology Times bladder cancer articles of 2025 Urology Times
HER2 in Bladder Cancer: A Frequent but Complex and Dynamic Biomarker - Daniele Raggi - UroToday
HER2 in Bladder Cancer: A Frequent but Complex and Dynamic Biomarker - Daniele Raggi UroToday
Bladder Cancer: What You Need to Know - University of Colorado Anschutz
Bladder Cancer: What You Need to Know University of Colorado Anschutz
Outcomes of sequential therapy for advanced upper tract urothelial cancer and bladder cancer - Nature
Outcomes of sequential therapy for advanced upper tract urothelial cancer and bladder cancer Nature
TPI1 enhances gemcitabine resistance in bladder cancer by promoting autophagy through activating Beclin-1 - Nature
TPI1 enhances gemcitabine resistance in bladder cancer by promoting autophagy through activating Beclin-1 Nature
Groundbreaking Advances for Patients with Muscle-Invasive Bladder Cancer and More to Come - Memorial Sloan Kettering Cancer Center
Groundbreaking Advances for Patients with Muscle-Invasive Bladder Cancer and More to Come Memorial Sloan Kettering Cancer Center
MD Anderson helps bladder cancer survivor through recurrences - UT MD Anderson
MD Anderson helps bladder cancer survivor through recurrences UT MD Anderson